Skip to main content
Clinical Trials/NCT06627933
NCT06627933Active, not recruitingNot Applicable

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement

I.M. Sechenov First Moscow State Medical University2 sites in 2 countries1,733 target enrollmentStarted: January 15, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
1,733
Locations
2
Primary Endpoint
Bleeding

Study Overview

Brief Summary

The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 95 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Informed consent
  • Age older than 18 y.o.
  • Cardiovascular disease
  • Indications for planned lower limb joint replacement surgery

Exclusion Criteria

  • Pregnancy
  • Psychiatric disorders
  • Decompensated heart failure or acute heart failure
  • Known diagnosis of cancer

Outcomes

Primary Outcomes

Bleeding

Time Frame: 6 months

All the cases of major and minor bleeding within 6 months

Thromboembolism

Time Frame: 6 months

All the cases of venous thromboembolism within 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olga Trushina

Professor

I.M. Sechenov First Moscow State Medical University

Study Sites (2)

Loading locations...

Similar Trials